These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 746466)

  • 1. Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias.
    Myers JB; Millar RN; Obel IW
    S Afr Med J; 1978 Dec; 54(26):1083-9. PubMed ID: 746466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiology of disopyramide in man.
    Ross D; Vohra J; Cole P; Hunt D; Sloman G
    Aust N Z J Med; 1978 Aug; 8(4):377-83. PubMed ID: 282851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
    Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of intravenous disopyramide phosphate on the Wolff-Parkinson-White syndrome.
    Tajima T; Dohi Y
    Pacing Clin Electrophysiol; 1982 Sep; 5(5):741-7. PubMed ID: 6182545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmia effect of disopyramide].
    Olbermann M; Just H; Guckenbiehl H; Lang KF
    Verh Dtsch Ges Inn Med; 1975; 81():152-5. PubMed ID: 1229482
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice].
    Grosu AA
    Kardiologiia; 1985 May; 25(5):114-8. PubMed ID: 3894756
    [No Abstract]   [Full Text] [Related]  

  • 13. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
    Bennett DH
    Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of disopyramide on normal and pathological atrioventricular conduction].
    Barnay C
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):449-53. PubMed ID: 1298185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
    Stauch M; Grewe N
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1563-6. PubMed ID: 74799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The electrophysiology of Norpace (Part III).
    Caracta A
    Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
    Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
    J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy and tolerance of disopyramide in arrhythmia associated with sinus node dysfunction].
    Brembilla-Perrot B; Vaur L
    Arch Mal Coeur Vaiss; 1991 Jun; 84(6):837-42. PubMed ID: 1898218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observations on effects of disopyramide on arrhythmias].
    Hu BL; Tao SQ; Liu LS; Chen ZJ; Lu ZL; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():60-2. PubMed ID: 6459881
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
    Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH
    Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.